Erica Friedman

Sep 13, 2024 | animeherald.com | Erica Friedman |Sean Gaffney |Samantha Ferreira

The American Manga Awards was an idea whose time had finally come. For years, as we watched manga be relegated to a tiny category among comic awards, many of the people in the industry had been saying that we really needed an awards celebration of our own. One of those people, journalist, podcaster, publisher, and catalyst for change, Deb Aoki, decided to do something about it.

Mar 16, 2024 | animeherald.com | Erica Friedman |Samantha Ferreira

Most people who are engaged in anime and manga fandoms have heard of the bi-annual Comic Market, “Comiket.” This massive event that attracts a quarter of a million attendees takes place in the summer, and again before New Year’s Day in Tokyo, Japan, at the event space known as “Big Sight.” Begun in 1975, Comiket has grown to become the world’s largest comic-media event.

Mar 7, 2024 | bioprocessintl.com | Cheryl Scott |Becky Cap |Erica Friedman |K.R. Poudel

With Anne Montgomery’s retirement this past November, I am now the last founder standing on the BPI staff. It began in 2002 as an idea from Brian Caine and Stephanie Schaffer on the business side with Anne and me on the editorial side, and we put out our first issue in January 2003. Now the brand includes conferences in Boston, San Diego, Europe, and Asia; a training academy; an online news outlet; webinars and custom publishing; and of course the publication that you hold in your hands.

Nov 14, 2023 | bioprocessonline.com | Erica Friedman |BioPlan Associates

Guest Column | November 14, 2023 By Erica Friedman, senior research analyst, BioPlan Associates Over the past 20 years that our Annual Biopharmaceutical Manufacturing Report1 has measured adoption of single-use systems (SUS) and modular technologies in bioprocessing, they have clearly become critical to bioprocessing. The trend continues to be driven by demand for efficiency and flexibility and the need for more innovative manufacturing.

Oct 4, 2023 | outsourcedpharma.com | Erica Friedman |BioPlan Associates |Louis Garguilo

Get more pharma outsourcing insight with our FREE newsletter Guest Column | October 4, 2023 By Erica Friedman, senior research analyst, BioPlan Associates Only a minority of biologics are manufactured entirely in-house, and that percentage continues to decline.